-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
November 20, 2013 - This needs to be made clearer in the description of
the studies throughout the report. … We used
the definition of HF as described by each author for
his/her study. … diagnostic
performance of the natriuretic peptides against the
reference criteria provided by each author … Race was checked and information added to the study
description section of KQ1, KQ2, KQ6 and KQ7. … We reported only those values that were reported by the
author and did not calculate LR+ or LR – if
-
effectivehealthcare.ahrq.gov/products/traumatic-brain-injury-rehabilitation/research-protocol
July 12, 2011 - with an estimated 1.7 million TBIs recorded annually between 2002 and 2006. 2 Of those injured each year … These fields will likely include author; year of publication; subject inclusion and exclusion criteria … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
May 27, 2010 - Online: May 27, 2010
2
Comment
Section
Comment Response
Introduction This section provided a description … Abstract No:
LBA6006
Citation:
J Clin Oncol 27:18s, 2009 (suppl; abstr LBA6006)
Author … This would be particularly unfortunate as these under-
65 year old patients are those who stand to benefit … Both RTOG 0022 and
0225 have demonstrated preliminary survival (89-91% 2-year locoregional disease
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
November 27, 2017 - There is a
need to account for the fact that the drugs available
on the street tend to vary from year … to year and
have recently focused on high potency, inexpensive
synthetic opioids and thus data from … Healthcare Research and Quality (AHRQ),
Rockville, MD, with the finding and views being
that of the author … & Affiliation Section Comment Response
Public
Reviewer #1,
Joi Kelly
General
Comments
The author … This includes description of
the same results in various discussion sections
provided.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
August 01, 2012 - See Table 1
for a crosswalk between year of diagnosis
and period of observation. … Age: We grouped women into five-year age groups by age at diagnosis. … Table 1: Description of the cohorts and the number of older women with ductal carci-
noma in situ and … Thus we see some
year-to-year differences where use rises
slightly in a later year than in an earlier … year.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
August 11, 2014 - troponin assays (e.g., did
study findings differ between those published early vs. late during
the 23 year … We ran our meta-analysis figures in order by
year to see if there was any evidence for a
temporal difference … However, this is a highly valuable document that provides
both detailed description and summaries of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
June 01, 2017 - The findings and conclusions in
this document are those of the author(s), who are responsible for its … Overall description of studies found ................................................................ … Overall description of studies found
Study Identifier
Papers Author,
year, PMID
Registry Prospective … ,
year, PMID
Registry Prospective/
retrospective
Dates Target N Key Question
NCT00579189 CT.gov … Arm details
Study Arm description
NCT00365092 TT inserted promptly
TT inserted up to 9 months later
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - We have deleted “physical and chemical” in the bone scan
description and now state that “bone scans … Findings
(continued)
Page 15 line 14-15: description of PET is simplistic. … We agree that a description of an ideal treatment evaluation
tool is helpful to this brief and have … More context
information may be helpful with basic description of a treatment
cycle, duration, timing … Peer Reviewer
#5
General
Comments
Good description of current studies on multiple tests.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
August 27, 2012 - description. … I found the description clearer
in the actual results section. … We have organized by alphabetically by
condition and then by author last name. … We have organized by alphabetically by
condition and then by author last name. … We have organized by alphabetically by
condition and then by author last name.
-
effectivehealthcare.ahrq.gov/products/asthma-immunotherapy/research-protocol
September 14, 2016 - Description of the intervention – Allergen-specific immunotherapy
Immunotherapy, as a treatment for … report will evaluate the safety of home administration (KQ2), looking at the evidence starting one year … For this question (KQ1), the evidence review will start one year prior to the end search date of the … was 2012, because of the change in scope, we will develop a broader search and search starting one year … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
December 21, 2010 - Report Characteristics
KQs 1–5
No limits on publication year or status
Publication language: … No limits will be placed on publication year or publication status. … reported:
Study and report characteristics: study design, study setting, duration of followup, first author … ,year and language of publication, funding source. … Comparison intervention characteristics: In placebo-controlled trials, description/definition of control
-
effectivehealthcare.ahrq.gov/products/dementia-databases-methods/research
May 22, 2008 - Author Affiliations
Ann L. … In the community, prescription fills are self-reported with a four-month recall (3 times a year). … Author Contributions
Author Name: Ann L. … Author Name: Ilene Zuckerman, Pharm. D., Ph.D. … Author Name: Linda Simoni-Wastila, R.Ph., Ph.D.
-
effectivehealthcare.ahrq.gov/products/antipsychotics-children-update/research-protocol
December 07, 2015 - listed below will be extracted as reported by study authors; for example, we will include relevant author-defined … Adverse effects will be recorded for each study group including the description of the AE, how it was … Author-defined outcomes for "treatment response" typically use values similar to our MID (e.g., 20-30 … Psychotropic practice patterns for youth: a 10-year perspective. … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - to the systematic reviews found that
among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain
Strategy Description … Patient-centered prescription opioid tapering
in community outpatients with chronic pain:
2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the
author … See Appendix B for detailed description of the criteria.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - It includes a reasonable background
literature description, it provides definitions for
relevant terminology … Did you follow this
approach and if yes, revise this description to improve
clarity. … We have revised some elements of the
description of the ACTIVE trial. … We have revised our description of the booster
assignment but it does not alter the bias
conclusion … They do a good job with their
description of how bias was rated.
-
effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - It includes a reasonable background
literature description, it provides definitions for
relevant terminology … Did you follow this
approach and if yes, revise this description to improve
clarity. … We have revised some elements of the
description of the ACTIVE trial. … We have revised our description of the booster
assignment but it does not alter the bias
conclusion … They do a good job with their
description of how bias was rated.
-
effectivehealthcare.ahrq.gov/products/integrated-pain-management/protocol
November 10, 2020 - reconditioning (e.g., PT, OT); studies may also include other components in addition to these; and
Description … (TIDieR) checklist in mind. 29 Elements will include, but not be limited to: study design, year, setting … Criteria for grading the quality of individual studies
Rating
Description and Criteria
Good … Description of the strength of evidence grades
Strength of Evidence
Description
High
We are … Better reporting of interventions: template for intervention description and replication (TIDieR) checklist
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition.pdf
May 04, 2017 - It states the searches
commenced with the year 2006 but what
was the end date of the reviews? … We have clarified the
description of self-
management programs in
the PICOTS table. … We have added a description
of our effect estimates in the
Methods section of the main
text under … We
used the same author name
to show it was the same
study but have now changed
it to the Healthy … We included a description of
the limitations of our review.
-
effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-disposition.pdf
May 04, 2017 - It states the searches
commenced with the year 2006 but what
was the end date of the reviews? … We have clarified the
description of self-
management programs in
the PICOTS table. … We have added a description
of our effect estimates in the
Methods section of the main
text under … We
used the same author name
to show it was the same
study but have now changed
it to the Healthy … We included a description of
the limitations of our review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-safety-practices-rapid-protocol.pdf
September 09, 2022 - Comparator • Usual care without PSP
• Care involving a different PSP
No clear description of intervention … Data extraction categories will include author, year, study design, characteristics of the patient